Literature DB >> 22160225

[New insights into the pathogenesis of sensitive skin].

E Proksch1, S Weidinger.   

Abstract

Many persons in the developed countries report sensitive skin. Persons with sensitive skin have a predisposition to several skin diseases, most importantly dry skin, but also atopy, seborrheic dermatitis, acne vulgaris, rosacea, and perioral dermatitis. Their complaints may be triggered by environmental factors such as low temperature, wind, high temperature, sun exposure and stress. Various skin care products and cosmetics are not tolerated. A disturbed skin barrier function and reduced stratum corneum water content are most important in the pathophysiology of sensitive skin. Environmental factors and cosmetics may induce irritation of the skin because of the disturbed skin barrier. Of further importance for the pathogenesis are neurogenic factors including stress and hyper-excitability. Mechanisms in signal transduction involve cytokines and neurotransmitters, but the exact pathways are unknown.

Entities:  

Mesh:

Year:  2011        PMID: 22160225     DOI: 10.1007/s00105-011-2209-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  28 in total

1.  Ethnic variations in self-perceived sensitive skin: epidemiological survey.

Authors:  R Jourdain; O de Lacharrière; P Bastien; H I Maibach
Journal:  Contact Dermatitis       Date:  2002-03       Impact factor: 6.600

2.  Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis.

Authors:  Alan D Irvine; W H Irwin McLean
Journal:  J Invest Dermatol       Date:  2006-06       Impact factor: 8.551

3.  Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany.

Authors:  A Ruether; M Stoll; T Schwarz; S Schreiber; R Fölster-Holst
Journal:  Br J Dermatol       Date:  2006-11       Impact factor: 9.302

Review 4.  The role of emollients in the management of diseases with chronic dry skin.

Authors:  E Proksch
Journal:  Skin Pharmacol Physiol       Date:  2008-01-11       Impact factor: 3.479

5.  Baseline biophysical parameters in subjects with sensitive skin.

Authors:  S Seidenari; M Francomano; L Mantovani
Journal:  Contact Dermatitis       Date:  1998-06       Impact factor: 6.600

6.  Epidemiologic Study of Malassezia Yeasts in Seborrheic Dermatitis Patients by the Analysis of 26S rDNA PCR-RFLP.

Authors:  Byung Ho Oh; Yang Won Lee; Yong Beom Choe; Kyu Joong Ahn
Journal:  Ann Dermatol       Date:  2010-05-17       Impact factor: 1.444

7.  Treatment of acute radiodermatitis with an oil-in-water emulsion following radiation therapy for breast cancer: a controlled, randomized trial.

Authors:  Jens-Michael Jensen; Tanja Gau; Jürgen Schultze; Gunter Lemmnitz; Regina Fölster-Holst; Theodor May; Christoph Abels; Ehrhardt Proksch
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

8.  Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.

Authors:  Erin M Warshaw; Ross Jon Wohlhuter; An Liu; Sarah A Zeller; Rachel A Wenner; Sacharitha Bowers; Julie C Schultz; H Irving Katz; Calogera L McCormick; Anne Parneix-Spake
Journal:  J Am Acad Dermatol       Date:  2006-12-22       Impact factor: 11.527

9.  In vivo transcutaneous penetration of nicotinates and sensitive skin.

Authors:  E Berardesca; M Cespa; N Farinelli; G Rabbiosi; H Maibach
Journal:  Contact Dermatitis       Date:  1991-07       Impact factor: 6.600

10.  Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris.

Authors:  Frances J D Smith; Alan D Irvine; Ana Terron-Kwiatkowski; Aileen Sandilands; Linda E Campbell; Yiwei Zhao; Haihui Liao; Alan T Evans; David R Goudie; Sue Lewis-Jones; Gehan Arseculeratne; Colin S Munro; Ann Sergeant; Gráinne O'Regan; Sherri J Bale; John G Compton; John J DiGiovanna; Richard B Presland; Philip Fleckman; W H Irwin McLean
Journal:  Nat Genet       Date:  2006-01-29       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.